Latest Regulation News

Alcoa Corporation has updated its dividend announcement to clarify currency exchange rates and payment options for its upcoming quarterly dividend, ensuring shareholders understand their payment choices and tax obligations.

Infomedia Ltd shareholders have overwhelmingly approved a scheme of arrangement for acquisition by TPG Capital, valuing the company at approximately AUD 651 million. The deal, supported by the board and an independent expert, is set to complete by early December 2025.

Virgin Money UK, trading as Clydesdale Bank, has applied to the High Court for approval to transfer its entire banking business to Nationwide Building Society, pending a February 2026 hearing.

IperionX rebuffs short seller claims by highlighting robust US government support and accelerating titanium production scale-up in Virginia. The company secures over $59 million in funding and advances critical minerals projects toward commercial readiness.

The Takeovers Panel has issued interim orders extending the deadline for Mayne Pharma's takeover scheme with Cosette Pharmaceuticals, preventing termination without consent and maintaining the status quo.

Australian Bond Exchange narrowed its FY25 loss by 26% through disciplined cost cuts and is advancing its fintech strategy with AI-driven credit tools and tokenised asset ambitions.

AXP Energy reports encouraging early oil and gas flowback at its Charlie #1 well in Oklahoma, marking a key milestone in its Mississippi Lime development program.

Infomedia Limited has secured Foreign Investment Review Board approval for its proposed acquisition by TPG Capital-backed McQueen BidCo, marking a key regulatory milestone. The Infomedia Board continues to recommend shareholder support ahead of upcoming votes.

Veganic SKN Ltd has launched legal action against Cancer Council Australia over alleged misleading claims about chemical UV filters in sunscreens, coinciding with recent product recalls and the company’s ambitious growth plans for 2026.

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.

Tombador Iron Limited reports a quarterly loss amid a strategic acquisition of GoviEx Uranium, signaling a pivot to uranium exploration and a rebrand to Atomic Eagle Limited.

Hartshead Resources has been granted a two-year extension on Phase C of its UK North Sea Licence P2607, allowing more time to complete its work programme amid regulatory and supply chain delays.